Multiplicom
Universiteit Antwerpen

Multiplicom

Biotech
Biotech
Biotech
Biotech

Acquired by Agilent Technologies.

Multiplicom was created in 2011 as a spin-off of the University of Antwerp and VIB. Multiplicom develops, manufactures and commercializes leading-edge and easy-to-use genetic test kits based on the latest molecular diagnostic technologies. Multiplicom produces molecular diagnostic kits that enable clinical laboratories to perform affordable testing for personalized medicine.

Acquired by Agilent Technologies.

No items found.

This company is aligned with the following SDGs

No items found.
EyeD Pharma
Qbic II
Medtech
Medtech
Medtech
Medtech

EyeD Pharma

EyeD Pharma is developing micro-implants for drug release over a prolonged period of time.

ULi├Ęge
Abscint
Qbic II
Biotech
Biotech
Biotech
Biotech

Abscint

ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.

VUB
UZ Brussel
Sentea
Qbic II
Deeptech
Deeptech
Deeptech
Deeptech

Sentea

Sentea leverages silicon photonics to develop a cost-effective fiber optic sensor interrogator.

Universiteit Gent
imec